SANDOZ' CPMS PATIENT MANAGEMENT SYSTEM MUST BE DELETED FROM CLOZARIL LABEL, FDA SAYS; LABEL SHOULD CITE MONITORING NEED, NOT COMMERCIAL VENTURE